The Effect Of Lebrikizumab Therapy On Key Type 2 Biomarkers In Moderate-To-Severe, Uncontrolled Asthma Patients: A Pooled Analysis From Phase 2 Trials
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要